BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35985690)

  • 1. Analysis of Protein-Protein Interactions Identifies NECTIN2 as a Target of
    Thongsom S; Aksorn N; Petsri K; Roytrakul S; Sriratanasak N; Wattanathana W; Chanvorachote P
    Cancer Genomics Proteomics; 2022; 19(5):624-635. PubMed ID: 35985690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel c-Myc-Targeting Compound
    Sriratanasak N; Petsri K; Laobuthee A; Wattanathana W; Vinayanuwattikun C; Luanpitpong S; Chanvorachote P
    Mol Pharmacol; 2020 Aug; 98(2):130-142. PubMed ID: 32487733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NECTIN2 is a prognostic biomarker and potential therapeutic target in lung adenocarcinoma.
    Ando T; Ka M; Sugiura Y; Tokunaga M; Nakagawa N; Iida T; Matsumoto Y; Watanabe K; Kawakami M; Sato M; Kage H
    Respir Investig; 2024 Jul; 62(4):582-588. PubMed ID: 38678829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the Protein-Protein Interaction Network Identifying c-Met as a Target of Gigantol in the Suppression of Lung Cancer Metastasis.
    Aksorn N; Losuwannarak N; Tungsukruthai S; Roytrakul S; Chanvorachote P
    Cancer Genomics Proteomics; 2021; 18(3):261-272. PubMed ID: 33893079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phoyunnanin E inhibits migration of non-small cell lung cancer cells via suppression of epithelial-to-mesenchymal transition and integrin αv and integrin β3.
    Petpiroon N; Sritularak B; Chanvorachote P
    BMC Complement Altern Med; 2017 Dec; 17(1):553. PubMed ID: 29284478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum nectin-2 and nectin-4 are diagnostic in lung cancer: which is superior?
    Erturk K; Karaman S; Dagoglu N; Serilmez M; Duranyildiz D; Tas F
    Wien Klin Wochenschr; 2019 Sep; 131(17-18):419-426. PubMed ID: 31440821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovalitenone Inhibits the Migration of Lung Cancer Cells via the Suppression of AKT/mTOR and Epithelial-to-Mesenchymal Transition.
    Sanookpan K; Nonpanya N; Sritularak B; Chanvorachote P
    Molecules; 2021 Jan; 26(3):. PubMed ID: 33530617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SOX9 drives the epithelial-mesenchymal transition in non-small-cell lung cancer through the Wnt/β-catenin pathway.
    Huang JQ; Wei FK; Xu XL; Ye SX; Song JW; Ding PK; Zhu J; Li HF; Luo XP; Gong H; Su L; Yang L; Gong LY
    J Transl Med; 2019 May; 17(1):143. PubMed ID: 31060551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glypican-5 suppresses Epithelial-Mesenchymal Transition of the lung adenocarcinoma by competitively binding to Wnt3a.
    Wang S; Qiu M; Xia W; Xu Y; Mao Q; Wang J; Dong G; Xu L; Yang X; Yin R
    Oncotarget; 2016 Nov; 7(48):79736-79746. PubMed ID: 27806326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of metastatic potential by inhibiting EGFR/Akt/p38/ERK signaling pathway and epithelial-mesenchymal transition after carbon ion exposure is potentiated by PARP-1 inhibition in non-small-cell lung cancer.
    Chowdhury P; Dey P; Ghosh S; Sarma A; Ghosh U
    BMC Cancer; 2019 Aug; 19(1):829. PubMed ID: 31438892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arenobufagin, isolated from toad venom, inhibited epithelial-to-mesenchymal transition and suppressed migration and invasion of lung cancer cells via targeting IKKβ/NFκB signal cascade.
    Zhao J; Zhang Q; Zou G; Gao G; Yue Q
    J Ethnopharmacol; 2020 Mar; 250():112492. PubMed ID: 31866511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Acidic Tumor Microenvironment Affects Epithelial-Mesenchymal Transition Markers as Well as Adhesion of NCI-H358 Lung Cancer Cells.
    Riemann A; Rauschner M; Gießelmann M; Reime S; Thews O
    Adv Exp Med Biol; 2021; 1269():179-183. PubMed ID: 33966214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 14. Mdig suppresses epithelial-mesenchymal transition and inhibits the invasion and metastasis of non‑small cell lung cancer via regulating GSK-3β/β-catenin signaling.
    Geng F; Jiang Z; Song X; Zhou H; Zhao H
    Int J Oncol; 2017 Dec; 51(6):1898-1908. PubMed ID: 29039479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTEN inactivation induces epithelial-mesenchymal transition and metastasis by intranuclear translocation of β-catenin and snail/slug in non-small cell lung carcinoma cells.
    Perumal E; So Youn K; Sun S; Seung-Hyun J; Suji M; Jieying L; Yeun-Jun C
    Lung Cancer; 2019 Apr; 130():25-34. PubMed ID: 30885348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isorhamnetin inhibited migration and invasion via suppression of Akt/ERK-mediated epithelial-to-mesenchymal transition (EMT) in A549 human non-small-cell lung cancer cells.
    Luo W; Liu Q; Jiang N; Li M; Shi L
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31467176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer.
    Ma K; Fan Y; Dong X; Dong D; Guo Y; Wei X; Ning J; Geng Q; Wang C; Hu Y; Li M; Niu W; Li E; Wu Y
    Oncotarget; 2017 Jun; 8(24):38825-38840. PubMed ID: 28418915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of ATM reverses EMT and decreases metastatic potential of cisplatin-resistant lung cancer cells through JAK/STAT3/PD-L1 pathway.
    Shen M; Xu Z; Xu W; Jiang K; Zhang F; Ding Q; Xu Z; Chen Y
    J Exp Clin Cancer Res; 2019 Apr; 38(1):149. PubMed ID: 30961670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer.
    Kachroo P; Lee MH; Zhang L; Baratelli F; Lee G; Srivastava MK; Wang G; Walser TC; Krysan K; Sharma S; Dubinett SM; Lee JM
    J Exp Clin Cancer Res; 2013 Nov; 32(1):97. PubMed ID: 24274066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of Feiyanning on the expression of epithelial-mesenchymal factors in highly metastatic lung cancer cells 95-D].
    Zhao X; Wu Z; Xu Z; Wang Z; Wu J; Su W
    Zhongguo Fei Ai Za Zhi; 2011 Jun; 14(6):467-71. PubMed ID: 21645447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.